Expression of swine MHC class II genes in a cynomolgus monkey: Retrovirus-mediated gene therapy in a preclinical transplantation model

Xenotransplantation

Volumn 4, Issue 3, 1997, Pages 174-185

  Banerjee, Papia T ^a   Lerino, Francesco L ^b   Kaynor, George C ^a   Giovino, Maria ^a   Hawley, Robert ^a   Rosa, Margaret D ^a   LeGuern, Christian ^b   Sachs, David H ^b   Monroy, Rodney ^a  

^a BioTransplant Inc   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bone marrow; Gene therapy; MHC; Monkey; Retrovirus; Swine; Tolerance; Xenograft

Indexed keywords

EID: 0000547578     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.1997.tb00181.x     Document Type: Article

References (55)

1. SACHS DH. The pig as a xenograft donor. Pathol Biol 1994: 42:217.
2. SYKES M, LEE LA, SACHS DH. Xenograft tolerance. Immunol Rev 1994:141:245.
3. SACHS DH, SABLINSKI T. Tolerance across discordant xenogeneic barriers. Xenotransplantation 1995:2:234.
4. ILDSTAD ST, SACHS DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984: 307:168.
5. COOPER DK. Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transplant Immunol 1993:1:198.
6. GALILI U. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: A major obstacle for xenotransplantation in humans. Immunol Today 1993:14:480.
7. FODOR WL, WILLIAMS BL, MATIS LA, MADRI JA, ROLLINS SA, KNIGHT JW, SQUINTO SP. Expression of a functional human complement inhibitor in a transgeneic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc Natl Acad Sci USA 1994:91:11153.
8. PLATT JL, FISCHEL RJ, MATAS AJ, REIF SA, BOLMAN RM, BACH FH. Immunopathology of hyperacute xenograft rejection in a swine to primate model. Transplantation 1991:52:214.
9. Cozzi E, WHITE DJG. The generation of transgeneic pigs as potential organ donors for humans. Nature Med 1995: 1:964.
10. YAMADA K, SEEBACH JD, DERSIMONIAN H, SACHS DH. Human anti-pig T-cell mediated cytotoxicity. Xenotransplantation 1996: 3:179.
11. YAMADA K, SACHS DH, DERSIMONIAN H. The human anti-porcine xenogeneic T-cell response: evidence for allelic specificity of MLR and both direct and indirect pathways of recognition. J Immunol 1995:155:5249.
12. SHARABI Y, SACHS DH. Mixed chimerism and permanent specific transplantation tolerance induced by non-lethal preparative regimen. J Exp Med 1989:169:493.
13. SHARABI Y, ABRAHAM VS, SYKES M, SACHS DH. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance. Bone Marrow Transplant 1992:9:191.
14. LEGUERN C, SHIMADA H, EMERY DW, GERMANA S, SHAFER GE, SACHS DH. Retrovirus-mediated transfer of MHC class II cDNA into swine bone marrow cells. J Mol Med 1995: 73:269.
15. FISHBEIN JM, ROSENGARD BR, GIANELLO P, NICKELEIT V, GUZZETTA PC, NAKAJIMA K, VITIELLO D, HILL GM, SACHS. DH. Development of tolerance to class II-mismatched renal transplants after a short course of cyclosporine therapy in miniature swine. Transplantation 1994:57:1303.
16. PESCOVITZ MD, THISTLETHWAITE JR, JR., AUCHINCLOSS H, JR., ILDSTAD ST, TERRILL R, SACHS DH. Effect of class II antigen matching on renal allograft survival in miniature swine. J Exp Med 1984:160:1495.
17. ROSENGARD BR, OJIKUTU CA, GUZZETTA PC, SMITH CV, SUNDT TM III, NAKAJIMA K, BOORSTEIN SM, HILL GS, FISHBEIN JM, SACHS DH. Induction of long-term specific tolerance to class I disparate renal allografts in miniature swine with a short course of cyclosporine. Transplantation 1992:54:490.
18. EMERY DW, SHAFER GE, KARSON EM, SACHS DH, LEGUERN C. Retrovirus-mediated transfer and expression of an allogeneic major histocompatibility complex class II DRB cDNA in swine bone marrow cultures. Blood 1993: 81:2460.
19. SHAFER GE, EMERY DW, GUSTAFSSON K, GERMANA S, ANDERSON WF, SACHS DH. Expression of a swine class II gene in murine bone marrow hematopoietic cells by retroviral-mediated gene transfer. Proc Natl Acad Sci USA 1991:88:9760.
20. EMERY DW, SABLINSKI T, ARN JS, LEGUERN C, SACHS DH. Bone marrow culture and transduction of stem cells in a miniature swine model. Blood Cells 1994:20:498.
21. SYKES M, SACHS DH, NIENHUIS AW, PEARSON DA, MOULTON AD, BODINE DM. Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic major histocompatibility complex gene. Transplantation 1993:55:197.
22. + monkey stem cells. Transplant Proc 1996:28:747.
23. EMERY DW, SABLINSKI T, SHULMAN S, FOLEY A, SACHS DH, LEGUERN C. Transfer and expression of retrovirus vectors for allogeneic class II MHC genes following bone marrow transduction and transplantation in miniature swine. Unpublished observation.
24. SMITH CV, NAKAJIMA K, MIXON A, GUZETTA PC, ROSENGARD BR, FISHBEIN JM, SACHS DH. Successful induction of long-term specific tolerance to fully allogeneic renal allografts in miniature swine. Transplantation 1992;53:438-444.
25. SABLINSKI T, EMERY DW, SHIMADA H, GERMANA S, GIANELLO P, FOLEY A, FISHMAN J, THOMAS L, NICKELEIT V, COLVIN RB, LEGUERN C, SACHS DH. Transfer of somatic MHC DRB transgene into bone marrow cells induces long-lasting unresponsiveness to a fully mismatched renal allograft. Unpublished observation.
26. SACHS DH. The pig as a potential xenograft donor. Vet Immunol Immunopathol 1994:43:185.
27. SACHS DH. MHC homozygous miniature swine. In: Swindle MM, Moody DS, Philips LD, eds. Swine as Model in Biomedical Research. Ames, IA: Iowa State University Press, 1992:3-15.
28. GUSTAFSSON K, GERMANA S, HIRSCH F, PRATT K, LEGUERN C, SACHS DH. Structure of miniature swine class II DRB genes: conservation of hypervariable amino acid residues between distantly related mammalian species. Proc Natl Acad Sci USA 1990:87:9798.
29. HIRSCH F, GERMANA S, GUSTAFSSON K, PRATT K, SACHS DH, LEGUERN C. Structure and expression of class II alpha genes in miniature swine. J Immunol 1992:149:841.
30. KAWAI T, COSIMI AB, COLVIN RB, POWELSON J, EASON J, KOZLOWSKI T, MONROY R, TANAKA M, SACHS DH. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995:59:256.
31. MACEJAK DG. AND SARNOW P. Internal initiation of translation mediated by the 5 leader of a cellular mRNA. Nature 1991:353:90.
32. JANG SK, KRAUSSLICH HG, NICKLIN MJ, DUKE GM, PALMENBERG AC, WIMMER EA. Segment of the 5′ non-translated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 1988:62:2636.
33. MILLER AD, ROSMAN GJ. Improved retroviral vectors for gene transfer and expression. Biotechniques 1989:7:980.
34. BOWTELL DD, JOHNSON GR, KELSO A, CORY S. Expression of genes transferred to haemopoietic stem cells by recombinant retroviruses. Mol Biol Med 1987:4:229.
35. BECK-ENGESER G, STOCKING C, JUST U, ALBRITTON L, DEXTER M, SPOONCER E., OSTERTAG W. Retroviral vectors related to myeloproliferative sarcoma virus allow efficient expression in hematopoietic stem and precursor cell lines, but retroviral infection is reduced in more primitive cells. Hum Gene Ther 1991:2:61.
36. FRASER CC, SYKES M, LEE RS, SACHS DH, LEGUERN C. Specific unresponsiveness to a retrovirally-transferred class I antigen is controlled through the helper pathway. J Immunol 1995:154:1587.
37. MILLER AD, BUTTIMORE C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 1986:6:2895.
38. KOTANI H, NEWTON PB, ZHANG S, CHIANG YL, OTTO E, WEAVER L, ANDERSON WF, MCGARRITY GJ. Improved methods of retroviral vector transduction and production for gene therapy. Hum Gene Ther 1994:5:19.
39. CORNETTA K, NGUYEN N, MORGAN RA, MUENCHAU DD, HARTLEY JW, BLAESE RM. Infection of human cells with murine amphotropic replication-competent retroviruses. Hum Gene Ther 1993:4:579.
40. PATHACK V, TEMIN HM. Broad spectrum of in vivo forward mutation, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: Deletions and deletions with insertions. Proc Natl Acad Sci USA 1990:87:6024.
41. Sharabi Y, Aksentijevich I, Sundt TM, Sachs DH, Sykes M. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med 1990:172:195.
42. GUZZETTA PC, SUNDT TM, SUZUKI T, MIXON A, ROSENGARD BR, SACHS DH. Induction of kidney transplantation tolerance across major histocompatibility complex barriers by BMT in miniature swine. Transplantation 1991:51:862.
43. SMITH CV, ROSENGARD BR, GUZZETTA PC, NAKAJIMA K, SACHS DH. New approaches to transplantation tolerance. Transplant Proc 1991:23:2157.
44. CHALLITA P, SKELTON D, EL-KHOUEIRY A, YU X, WEINBERG K, KOHN DB. Multiple modification in cis elements of the long terminal repeat of the retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J Virol 1995:69:748.
45. CHALLITA P, KOHN DB. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci USA 1994:91:2567.
46. STOCKING C, KOLLEK R, BERGHOLZ U, OSTERTAG W. Long terminal repeat sequences impart hematopoietic transformation properties to myeloproliferative sarcoma virus. Proc Natl Acad Sci USA 1994:82:5746.
47. VAN BEUSCHEM VW, VALERIO D. Gene transfer into hematopoietic stem cells of nonhuman primates. Hum Gene Ther 1996:7:1649.
48. DONAHUE RE, KESSLER SW, BODINE D, MCDONAGH K, DUNBAR C, GOODMAN S, BYRNE E, RAFFELD M, MOEN R, BACHER J, ZSEBO KM, NEINHUIS AW. Helper virus induced T cell lymphoma in non-human primates after retroviral mediated gene transfer. J Exp Med 1992:176:1125.
49. + bone marrow cells. Blood 1993:82:1975.
50. + hematopoietic cell transduction with cell-free retroviral vector preparations. Proc Natl Acad Sci USA 1995:92:4372.
51. KOHN DB, WEINBERG KI, NOLTA JA, HEISS LN, LENARSKY C, CROOKS GM, HANLEY ME, ANNETT G, BROOKS JS, EL-KHOUREY A, LAWRENCE K, WELLS S, MOEN RC, BASTIAN J, WILLIAMS-HERMAN DE, ELDER M, WARA D, BOWEN T, HERSHFIELD MS, MULLEN CA, BLAESE RM, PARKMAN R. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Med 1995:1:1017.
52. VAN BEUSECHEM VW, KUKLER A, HEIDT PJ, VALERIO D. Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. Proc Natl Acad Sci USA 1992:89:7640.
53. TANAKA M, LATINNE D, GIANELLO P, SABLINSKI T, LORF T, BAILIN M, COLVIX R, LEBOWITZ E, SYKES M, COSIMI AB, SACHS DH. Xenotransplantation from pig to cynomolgus monkey: the potential for overcoming xenograft rejection through induction of chimerism. Transplant Proc 1994:26:1326.
54. THOMAS JM, CARVER MC, KASTEN-JOLLY J, HAISCH CE, REBELLATO LM, GROSS U, VORE SJ, THOMAS FT. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 1994:57:101.
55. AUCHINCLOSS H JR, LEE R, SHEA S, MARKOWITZ JS, GRUSBY MJ, GLIMCHER LH. The role of indirect recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci USA 1993:90:3373.